Clinical trial
The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery
NCT07125573 is registered in ClinicalTrials.gov with First Affiliated Hospital of Kunming Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery
- Lead sponsor
- First Affiliated Hospital of Kunming Medical University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- May 1, 2025
- Completion date
- April 1, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esketamine plus dexmedetomidine affect postoperative quality, lung neoplasms, thoracoscopy